AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while ...
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. Don't Miss our Black Friday Offers:Unlock your ...
Spanish drugmaker PharmaMar Group revealed that its licensing partner, Luye Pharma Group, has received conditional marketing ...
Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...
The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...
Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health ...
French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...
Hosted on MSN20h
Trump 2.0 could see a rise in biopharmaceutical M&A dealsA change in FTC leadership would likely see a relaxation of antitrust enforcement and an increase in biopharma M&A activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback